- Drug Manufacturers - General
- Healthcare
Biogen Inc.
BIIB · US ·
NASDAQ
200.13
USD
+1.74
(0.87%)
-
7.96
EPS
-
25.15
P/E
-
29.2B
MARKET CAP
-
0.00%
DIV YIELD
EPS Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 8.56 | 16.6 | 22.9 | 24.1 | 22.2 | 24.5 | 23.39% |
| Avg. Estimate | 7.98 | 16 | 14.1 | 17 | 20.7 | 22.8 | 23.39% |
| Low Estimate | 7.43 | 15.5 | 8.94 | 12.4 | 19.3 | 21.3 | 23.39% |
| No. Of Analysts | 23 | 29 | 24 | 12 | 5 | 7 |
Revenue Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 9.82B | 9.8B | 10.4B | 10.4B | 11B | 11.3B | 2.79% |
| Avg. Estimate | 9.67B | 9.61B | 9.58B | 9.83B | 10.4B | 10.7B | 1.99% |
| Low Estimate | 9.53B | 9.42B | 8.68B | 9.31B | 9.82B | 10.1B | 1.19% |
| No. Of Analysts | 29 | 29 | 30 | 25 | 12 | 11 |
Net Income Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 1.39B | 2.41B | 3.33B | 3.51B | 3.23B | 3.57B | 20.72% |
| Avg. Estimate | 1.16B | 2.33B | 2.15B | 2.48B | 3.02B | 3.33B | 23.48% |
| Low Estimate | 927M | 2.26B | 1.3B | 1.81B | 2.81B | 3.1B | 27.28% |
| No. Of Analysts | 29 | 29 | 30 | 25 | 12 | 11 |